- Home
- CTSO vs MGLD Comparison
CTSO vs MGLD Comparison
Compare CTSO & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- MGLD
- Stock Information
- Founded
- CTSO 1997
- MGLD 1996
- Country
- CTSO United States
- MGLD United States
- Employees
- CTSO N/A
- MGLD N/A
- Industry
- CTSO Medical/Dental Instruments
- MGLD Finance/Investors Services
- Sector
- CTSO Health Care
- MGLD Finance
- Exchange
- CTSO Nasdaq
- MGLD Nasdaq
- Market Cap
- CTSO 51.6M
- MGLD 45.4M
- IPO Year
- CTSO N/A
- MGLD N/A
- Fundamental
- Price
- CTSO $1.15
- MGLD $0.97
- Analyst Decision
- CTSO Strong Buy
- MGLD
- Analyst Count
- CTSO 3
- MGLD 0
- Target Price
- CTSO $4.67
- MGLD N/A
- AVG Volume (30 Days)
- CTSO 147.4K
- MGLD 68.0K
- Earning Date
- CTSO 03-06-2025
- MGLD 03-04-2025
- Dividend Yield
- CTSO N/A
- MGLD N/A
- EPS Growth
- CTSO N/A
- MGLD N/A
- EPS
- CTSO N/A
- MGLD N/A
- Revenue
- CTSO $37,739,531.00
- MGLD $32,057,000.00
- Revenue This Year
- CTSO $9.20
- MGLD N/A
- Revenue Next Year
- CTSO $11.64
- MGLD N/A
- P/E Ratio
- CTSO N/A
- MGLD N/A
- Revenue Growth
- CTSO 1.80
- MGLD N/A
- 52 Week Low
- CTSO $0.70
- MGLD $0.95
- 52 Week High
- CTSO $1.61
- MGLD $2.10
- Technical
- Relative Strength Index (RSI)
- CTSO 55.74
- MGLD 33.18
- Support Level
- CTSO $1.06
- MGLD $1.00
- Resistance Level
- CTSO $1.61
- MGLD $1.16
- Average True Range (ATR)
- CTSO 0.13
- MGLD 0.07
- MACD
- CTSO 0.01
- MGLD 0.01
- Stochastic Oscillator
- CTSO 29.34
- MGLD 0.37
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About MGLD The Marygold Companies Inc.
The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.